MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
A3321 Cobimetinib3 CitationSummary: Selective MEK inhibitor
-
A3322 Cobimetinib (racemate)Summary: Selective MEK inhibitor
-
A3323 Cobimetinib (R-enantiomer)Summary: Selective MEK inhibitor
-
A3594 MEK inhibitorSummary: Potent MEK inhibitor, Antitumor agent
-
A3805 SCH7729847 CitationSummary: ERK1 and ERK2 inhibitor
-
A3887 Trametinib DMSO solvate1 CitationTarget: MEKSummary: Allosteric MEK1/MEK2 kinase inhibitor
-
B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor
-
B1135 GDC-0623Target: MEKSummary: MEK1 inhibitor, potent and ATP-uncompetitive
-
A8374 AZD8330Target: MEKSummary: MEK 1/2 inhibitor
-
B3261 RO4987655Summary: MEK inhibitor